In animal models, genetic or pharmacological inhibition of PTP1B enhanced endothelial cell proliferation and NO production, and could also reverse septic endothelial dysfunction (5, 6, 9, 25). This evidence concerns the gene PTPN1 and endothelial dysfunction.